On 2025-12-11, Evommune Inc. (EVMN) announced earnings per share of $-8.07 for the fiscal quarter ending 2025-09-30, missing the average analyst estimate of $-6.58.

The next expected annoucement date for quarterly earnings is 2026-03-12, with an average estimated earnings per share of $-1.05 for the fiscal quarter ending 2025-12-31.

Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.